首页> 外文OA文献 >SHR ‐A1403, a novel c‐mesenchymal‐epithelial transition factor (c‐Met) antibody‐drug conjugate, overcomes AZD 9291 resistance in non‐small cell lung cancer cells overexpressing c‐Met

【2h】

SHR ‐A1403, a novel c‐mesenchymal‐epithelial transition factor (c‐Met) antibody‐drug conjugate, overcomes AZD 9291 resistance in non‐small cell lung cancer cells overexpressing c‐Met

机译：SCR -A1403，一种新型C-间充质 - 上皮过渡因子（C-MET）抗体 - 药物缀合物克服了过表达C-MET的非小细胞肺癌细胞中的AZD 9291抗性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Mengya Tong; Mingzhao Gao; Yongping Xu; Li Fu; Yun Li; Xubin Bao; Haoyu Fu; Haitian Quan; Liguang Lou;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. SHR‐A1403, a novel c‐mesenchymal‐epithelial transition factor (c‐Met) antibody‐drug conjugate, overcomes AZD9291 resistance in non‐small cell lung cancer cells overexpressing c‐Met [J] . Mengya Tong, Mingzhao Gao, Yongping Xu, Cancer science. . 2019 ,第11期

机译：SHR-A1403，一种新型的C-间充质 - 上皮过渡因子（C-MET）抗体 - 药物缀合物克服过表达C-MET的非小细胞肺癌细胞中的AZD9291抗性
2. Loss of EGFR confers acquired resistance to AZD9291 in an EGFR-mutant non-small cell lung cancer cell line with an epithelial-mesenchymal transition phenotype [J] . Xu Jing, Zhao Xiaoting, He Dengfeng, Journal of Cancer Research and Clinical Oncology . 2018 ,第8期

机译：EGFR的损失赋予AZD9291在EGFR-突变体非小细胞肺癌细胞系中获得的抗性，具有上皮 - 间充质转换表型
3. MA07.10 HDAC Inhibition Overcomes Crizotinib-Resistance by Mesenchymal-Epithelial Transition (MET) in EML4-ALK Lung Cancer Cells [J] . Koji Fukuda, Shinji Takeuchi, Ryohei Katayama, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017 ,第1期

机译：MA07.10 HDAC抑制通过EML4-ALK肺癌细胞中间充质上皮转换（MET）克服了颅滴抗性
4. Epithelial mesenchymal transition in lung cancer cells: A quantitative analysis [C] . Sarkar Atasi, Barui A., Sengupta S., Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2015

机译：肺癌细胞上皮间质转化的定量分析
5. Design and Evaluation of Peptidomimetics and Peptidomimetics Drug Conjugates Targeting HER2 Overexpressing Cells in Breast and Lung Cancers [D] . Pallerla, Sandeep. 2017

机译：拟肽和拟肽药物结合物靶向乳腺癌和肺癌中HER2过表达细胞的设计和评估
6. SHR‐A1403 a novel c‐mesenchymal‐epithelial transition factor (c‐Met) antibody‐drug conjugate overcomes AZD9291 resistance in non‐small cell lung cancer cells overexpressing c‐Met [O] . Mengya Tong, Mingzhao Gao, Yongping Xu, 2019

机译：SHR-A1403是一种新型的c-间质-上皮转化因子（c-Met）抗体-药物偶联物克服了过表达c-Met的非小细胞肺癌细胞的AZD9291耐药性
7. Role of Wnt Inhibitory Factor-1 in Inhibition of Bisdemethoxycurcumin Mediated Epithelial-to-Mesenchymal Transition in Highly Metastatic Lung Cancer 95D Cells [O] . Jin-Hong Xu, He-Ping Yang, Xiang-Dong Zhou, 2015

机译：Wnt抑制因子-1在抑制双去甲氧基姜黄素介导的高转移性肺癌95D细胞上皮 - 间质转化中的作用

SHR ‐A1403, a novel c‐mesenchymal‐epithelial transition factor (c‐Met) antibody‐drug conjugate, overcomes AZD 9291 resistance in non‐small cell lung cancer cells overexpressing c‐Met

著录项

相似文献

相关主题

期刊订阅